This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.

US lawmakers urge FTC to release second interim report on PBMs

( January 10, 2025, 18:13 GMT | Official Statement) -- MLex Summary: US Senators Elizabeth Warren and Josh Hawley and Representatives Diana Harshbarger and Jake Auchincloss wrote a letter urging the Federal Trade Commission to vote in favor of releasing a second interim report on prescription drug middlemen, or pharmacy benefit managers, at the agency's upcoming Open Commission hearing on Jan. 14, 2025. The FTC’s interim report helped inform various bipartisan proposals to rein in abuses in the PBM market, including the Patients Before Monopolies (PBM) Act, the lawmakers said. "We expect a second interim report will shine further light on the industry that will be invaluable to legislators as the policy priorities of the 119th Congress take shape," they said....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections